OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
6
Results
Show all
Save search
Copy query
Show results for
Unknown
(6)
Publication Date
Release Date
2026
(1)
2024
(1)
2023
(1)
2022
(1)
2021
(1)
2019
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis: The Phase 3 ECZTRA 6 Randomized Clinical Trial.
Not available
S-EPMC10116386
|
biostudies-literature
Cite
Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28-week clinical and biomarker results from the BioDay registry.
Not available
S-EPMC10107870
|
biostudies-literature
Cite
Contact Allergy in Children in Europe: A Proposal for a Paediatric European Baseline Series.
Not available
S-EPMC12695515
|
biostudies-literature
Cite
Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry.
Not available
S-EPMC10863496
|
biostudies-literature
Cite
Defining and measuring 'eczema control': an international qualitative study to explore the views of those living with and treating atopic eczema.
Not available
S-EPMC6594222
|
biostudies-literature
Cite
European Surveillance System on Contact Allergies (ESSCA): Characteristics of patients patch tested and diagnosed with irritant contact dermatitis.
Not available
S-EPMC8360089
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets